Toronto - Delayed Quote CAD

Burcon NutraScience Corporation (BU.TO)

0.2450 +0.0150 (+6.52%)
At close: April 26 at 3:59 PM EDT
Key Events
Loading Chart for BU.TO
DELL
  • Previous Close 0.2300
  • Open 0.2200
  • Bid 0.2400 x --
  • Ask 0.2500 x --
  • Day's Range 0.2200 - 0.2750
  • 52 Week Range 0.1000 - 0.3500
  • Volume 64,415
  • Avg. Volume 44,342
  • Market Cap (intraday) 34.797M
  • Beta (5Y Monthly) 2.50
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2100
  • Earnings Date Jun 20, 2024 - Jun 24, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Burcon NutraScience Corporation, together with its subsidiaries, develops plant proteins and ingredients for use in the food and beverage industries in Canada. The company offers Peazazz and Peazac, a pea protein for use in dairy alternatives, ready-to-drink beverages, dry blended beverages, bars, baked goods, and meat substitute products. It provides Puratein, a canola protein isolate for use in meat alternatives, such as burgers, sausages, and nutrition bars; Supertein, a canola protein that is a light-colored powder for use in non-dairy frozen desserts, egg alternative, plant-based marshmallows and ready-to-mix beverages, whipped toppings, and plant-based bars; and Nutratein, a canola protein comprising a mixture of globulin and albumin proteins for use in meat and egg alternatives, and other plant-based functional foods. In addition, the company offers Nutratein-PS, a blend of Peazazz pea protein and Supertein canola protein; Nutratein-TZ, a blend of Peazac pea protein and Puratein canola protein; and CLARISOY, a soy protein for use in sports nutrition beverages, citrus-based drinks, fruit-flavored beverages, lemonades, powdered beverage mixes, and non-beverage plant-based products. The company was formerly known as Burcon Capital Corp. and changed its name to Burcon NutraScience Corporation in October 1999. The company was incorporated in 1998 and is headquartered in Vancouver, Canada.

www.burcon.ca

24

Full Time Employees

March 31

Fiscal Year Ends

Recent News: BU.TO

Performance Overview: BU.TO

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BU.TO
11.36%
S&P/TSX Composite index
4.82%

1-Year Return

BU.TO
2.00%
S&P/TSX Composite index
7.48%

3-Year Return

BU.TO
95.13%
S&P/TSX Composite index
15.01%

5-Year Return

BU.TO
15.52%
S&P/TSX Composite index
32.54%

Compare To: BU.TO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BU.TO

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    34.80M

  • Enterprise Value

    36.51M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    99.07

  • Price/Book (mrq)

    6.00

  • Enterprise Value/Revenue

    133.54

  • Enterprise Value/EBITDA

    -1.66

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -45.14%

  • Return on Equity (ttm)

    -169.75%

  • Revenue (ttm)

    184.36k

  • Net Income Avi to Common (ttm)

    -7.21M

  • Diluted EPS (ttm)

    -0.2100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    675.38k

  • Total Debt/Equity (mrq)

    190.99%

  • Levered Free Cash Flow (ttm)

    -2.88M

Company Insights: BU.TO

People Also Watch